Fig. 5From: Kinetics of CD169, HLA-DR, and CD64 expression as predictive biomarkers of SARS-CoV2 outcomeExamples of some of the many possible findings in the monitoring of SARS-CoV2-infected patients undergoing sepsis during their clinical follow-up. Upper row (a): Moderate neCD64 upregulation, normal moHLA-DR expression, and cleared SARS-CoV2, with normal moCD169 expression. This patient showed normal immune competence and recovered from sepsis. Lower row (b): Moderate neCD64 upregulation, severe moHLA-DR downregulation, and just slightly increased moCD169. This patient died for infectious complications, despite having effectively cleared the SARS-CoV2Back to article page